Kathleen A. Bridges - Concepedia

Author

Kathleen A. Bridges

The University of Texas MD Anderson Cancer Center

Also Known As

, Kathleen A. Bridges, Kathleen Bridges

Publications

530

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center UPMC Hillman Cancer Center Merck & Co., Inc., Rahway, NJ, USA (United States)Baylor College of Medicine Gwynedd Mercy University

About

Kathleen A. Bridges is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, redox biology, and molecular oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	75
2	Biochemistry	1	1	38
3	Cell Biology	1	1	37
4	Pharmacology	1	1	38
5	Radiation Medicine	1	1	37

Kathleen A. Bridges

Publications

509

Citations

H-Index

Page 1

	Year	Citations
MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells Kathleen A. Bridges, Hiroshi Hirai, Carolyn A. Buser, Clinical Cancer Research	2011	231
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells Kathleen A. Bridges, Carlo Toniatti, Carolyn A. Buser, Oncotarget	2014	55
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints Jessica M. Molkentine, David Molkentine, Kathleen A. Bridges, International Journal of Radiation Biology	2020	41
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress Adrienne Howard, Kathleen A. Bridges, Raymond E. Meyn, Cancer Chemotherapy and Pharmacology Reductive StressBiochemistryMedicineReactive Oxygen SpeciePharmacology	2009	38
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer Colin Brooks, Tommy Sheu, Kathleen A. Bridges, Radiation Oncology	2012	37
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells Kathleen A. Bridges, Xingxing Chen, Huifeng Liu, Oncotarget Radiation EffectCell DeathDsb RepairChk1 Kinase InhibitorRadiation Biology	2016	37
Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function Manish Kumar, David Molkentine, Jessica M. Molkentine, Nature Communications	2021	35
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade David Molkentine, Jessica M. Molkentine, Kathleen A. Bridges, Cancer Research	2021	35

Page 1